The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Cloud and showery rain may linger across the far northwest throughout Saturday.
Supporters of the British man who is awaiting release from Guantanamo Bay spoke to ITV News about their concerns for his health.
For the NHS to remain at the centre of our lives, it will have to change how it treats us or we will have to change how we treat it.